CUTOLO, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 62.869
Totale 62.869
Nazione #
IT - Italia 62.869
Totale 62.869
Città #
Genova 49.232
Rapallo 5.497
Genoa 5.311
Vado Ligure 2.672
Bordighera 157
Totale 62.869
Nome #
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. 513
1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. 189
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 162
The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases 156
Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal 153
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 152
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 149
Androgens in rheumatoid arthritis: when are they effectors? 148
Steroids and Autoimmunity 146
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 146
Zinc concentrations in rheumatoid and psoriatic arthritis. Are they relevant to the inflammatory process? 145
Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. 142
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 142
Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. 141
Functional study of glenohumeral ligaments. 139
Evolutionary medicine and bone loss in chronic inflammatory diseases-A theory of inflammation-related osteopenia 138
Rheumatoid arthritis: circadian and circannual rhythms in RA. 136
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. 136
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 136
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. 135
Special issue on glucocorticoid therapy in rheumatic diseases: introduction 135
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 134
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 134
Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines 133
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 132
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 131
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice 131
Cross-cultural adaptation and validity of the Italian version of the Central Sensitization Inventory 131
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). 131
[CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture] 129
Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis 129
Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. 128
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 128
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 128
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. 128
Timing of transition between capillaroscopic patterns in systemic sclerosis. 127
Pregnancy, cytokines and disease activity in systemic lupus erythematosus 127
Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. 126
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 126
Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. 125
Atlas of Capillaroscopy in Rheumatic Diseases 125
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. 125
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 125
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. 124
Therapy. Optimized treatment algorithms for digital vasculopathy in SSc. 124
Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. 124
Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. 123
Lack of sialic acid in synovial fluid fibronectin. 123
Acral localized acquired cutis laxa associated with rheumatoid arthritis. 123
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 123
Vitamin D endocrine system involvement in autoimmune rheumatic diseases 123
Nocturnal hormones and clinical rhythms in rheumatoid arthritis. 122
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. 122
Air Travel, Circadian Rhythms/Hormones, and Autoimmunity. 122
Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis. 121
Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study 121
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 121
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 121
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 121
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 120
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 119
Systemic sclerosis: state of the art on clinical practice guidelines 119
Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? 119
Vitamin D endocrine system and the immune response in rheumatic diseases. 118
Androgen replacement therapy in male patients with rheumatoid arthritis. 118
2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis 118
Immunomodulatory mechanisms mediated by sex hormones in rheumatoid arthritis. 117
The controversy over zinc sulphate efficacy in rheumatoid and psoriatic arthritis. 117
Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis. 117
Nail involvement in osteoarthritis. 117
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis 117
Estrogen's effects in chronic autoimmune/inflammatory diseases and progression to cancer 117
Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain 116
Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis 116
Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients. 116
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 115
Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study 115
Phorbol diester 12-O-tetradecanoylphorbol 13-acetate (TPA) up-regulates the expression of estrogen receptors in human THP-1 leukemia cells. 114
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. 114
Review: vitamin D, immunity and lupus. 114
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 114
Hypocupremia-related hypochromic anemia during D-penicillamine treatment. 114
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients 114
Stress as a risk factor in the pathogenesis of rheumatoid arthritis. 113
Adult-onset Still's disease associated to toxoplasma gondii infection. 113
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 113
Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. 113
Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy. 113
Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. 113
EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. 113
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 113
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. 112
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 112
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. 112
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey). 112
Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action. 111
Estrogens in pregnancy and systemic lupus erythematosus. 111
Evidence for soluble and nuclear site I binding of estrogens in human aorta. 111
Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis 111
Evidence of cerebral hypoperfusion in scleroderma patients. 111
Totale 12.932
Categoria #
all - tutte 187.128
article - articoli 177.679
book - libri 0
conference - conferenze 6.892
curatela - curatele 236
other - altro 135
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.186
Totale 374.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015.783 0 0 0 0 1.681 1.921 2.959 1.399 1.743 3.269 2.071 740
2020/20215.401 313 396 872 368 378 467 276 416 567 552 387 409
2021/20228.378 239 593 656 959 201 481 581 2.043 473 795 323 1.034
2022/20236.782 806 249 50 569 1.237 1.159 47 662 1.194 61 660 88
2023/20244.131 187 657 83 378 299 647 258 343 192 80 238 769
2024/20253.015 428 1.111 410 747 319 0 0 0 0 0 0 0
Totale 64.699